Dr Beardsley is an infectious disease specialist, fellow of the Royal Australasian College of Physicians, and clinical researcher. He completed his PhD through the Oxford University Clinical Research Unit in Ho Chi Minh City, focussed on fungal infections. He conducted a multi-national randomised clinical trial into adjunctive steroid therapy for Cryptococcal Meningitis in South East Asia and Africa (Beardlsey et al, NEJM 2016). His other core research focussed on epidemiology of fungal infections, immune responses in Cryptococcal Meningitis, pharmacokinetics of anti-fungal drugs in the central nervous system, and temporal trends in cryptococcal drug susceptibility. He was involved in several other clinical trials in Cryptococcal Meningitis and hepatitis C, and is a co-author on the Lancet Global Burden of Disease series in his capacity as GBD specialist on Vietnam and HIV.